Miami-based Sylvester Comprehensive Cancer Center received a $50 million gift from Kenneth Griffin, founder and CEO of Citadel and founder of Griffin Catalyst.
Author: Mariah Taylor
Denosumab, a bone-modifying agent for cancer treatment, is being overused and costing Medicare more than $43 million each year, a recent Memorial Sloan Kettering study found.
Cancer patients who undergo surgery and have a behavioral health disorder have higher odds of a complication, prolonged length of stay and 90-day readmission, a recent study found.
Five of the top 10 oncology hospitals in the world are based in the U.S., according to Newsweek's 2024 "World's Best Specialized Hospitals" list.
Tampa, Fla.-based Moffitt Cancer Center named Jonathan Zager, MD, physician of the year.
Advertisement
Marcel van den Brink, MD, PhD, started his career in "the real Holland with the windmills, tulip fields and all that good stuff." But he left all of it behind in the late 1980s to complete his oncology training in…
A recent Alabama Supreme Court ruling that frozen embryos are considered children under the law has worried cancer patients who use in vitro fertilization to preserve their reproductive options, The Washington Post reported Feb. 25.
Los Angeles-based City of Hope launched its new mobile program — the first in the country to provide mobile comprehensive cancer prevention and screening services for 15 cancers.
Jonathan Uhr, MD, a medical researcher who expanded knowledge on antibodies and cancer treatments, died of prostate cancer on Feb. 15. He was 96, The Washington Post reported.
The University of Cincinnati Cancer Center is the first site in the Midwest to launch a phase 2 clinical trial to test a pancreatic cancer vaccine.